Regulation of PBX3 expression by androgen and Let-7d in prostate cancer

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Ramberg, Håkon ^a,b   Alshbib, Ayham ^a,b   Berge, Viktor ^a   Svindland, Aud ^a   Taskén, Kristin A ^a,b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; LET 7D; MICRORNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PBX3; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MIRNLET7 MICRORNA, HUMAN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN PBX3; PROTO-ONCOGENE PROTEIN PBX3;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; UPREGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANDROGEN;

EID: 79955669927     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-50     Document Type: Article

References (37)

1. Laurent A, Bihan R, Omilli F, Deschamps S, Pellerin I. PBX proteins: much more than Hox cofactors. Int J Dev Biol 2008, 52:9-20. 10.1387/ijdb.072304al, 18033668.
2. Schnabel CA, Selleri L, Jacobs Y, Warnke R, Cleary ML. Expression of Pbx1b during mammalian organogenesis. Mech Dev 2001, 100:131-135. 10.1016/S0925-4773(00)00516-5, 11118899.
3. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990, 60:547-555. 10.1016/0092-8674(90)90658-2, 1967983.
4. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990, 60:535-545. 10.1016/0092-8674(90)90657-Z, 1967982.
5. Monica K, Galili N, Nourse J, Saltman D, Cleary ML. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol Cell Biol 1991, 11:6149-6157. 361792, 1682799.
6. Wagner K, Mincheva A, Korn B, Lichter P, Popperl H. Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. Mech Dev 2001, 103:127-131. 10.1016/S0925-4773(01)00349-5, 11335119.
7. Milech N, Kees UR, Watt PM. Novel alternative PBX3 isoforms in leukemia cells with distinct interaction specificities. Genes Chromosomes Cancer 2001, 32:275-280. 10.1002/gcc.1190, 11579467.
8. Di GG, Koss M, Capellini TD, Brendolan A, Popperl H, Selleri L. Spatio-temporal expression of Pbx3 during mouse organogenesis. Gene Expr Patterns 2006, 6:747-757. 10.1016/j.modgep.2005.12.002, 16434237.
9. Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, et al. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology 2007, 148:693-704.
10. Ogo A, Waterman MR, McAllister JM, Kagawa N. The homeodomain protein Pbx1 is involved in cAMP-dependent transcription of human CYP17. Arch Biochem Biophys 1997, 348:226-231. 10.1006/abbi.1997.0372, 9390195.
11. Gregory PA, Mackenzie PI. The homeodomain Pbx2-Prep1 complex modulates hepatocyte nuclear factor 1alpha-mediated activation of the UDP-glucuronosyltransferase 2B17 gene. Mol Pharmacol 2002, 62:154-161. 10.1124/mol.62.1.154, 12065766.
12. Rhee JW, Arata A, Selleri L, Jacobs Y, Arata S, Onimaru H, Cleary ML. Pbx3 deficiency results in central hypoventilation. Am J Pathol 2004, 165:1343-1350. 10.1016/S0002-9440(10)63392-5, 1618620, 15466398.
13. Qiu Y, Tomita Y, Zhang B, Nakamichi I, Morii E, Aozasa K. Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth. Am J Pathol 2007, 170:152-159. 10.2353/ajpath.2007.060722, 1762682, 17200190.
14. Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer 2010, 10:89. 10.1186/1471-2407-10-89, 2846885, 20219106.
15. Shears L, Plowright L, Harrington K, Pandha HS, Morgan R. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol 2008, 180:2196-2201. 10.1016/j.juro.2008.07.018, 18804814.
16. Plowright L, Harrington KJ, Pandha HS, Morgan R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009, 100:470-475. 10.1038/sj.bjc.6604857, 2658540, 19156136.
17. Aulisa L, Forraz N, McGuckin C, Hartgerink JD. Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater 2009, 5:842-853. 10.1016/j.actbio.2008.11.002, 19249722.
18. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol 2003, 5:R1. 10.1186/gb-2003-5-1-r1, 395733, 14709173.
19. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
20. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, Macmenamin P, da P, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
21. Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K, Tanji N, Yokoyama M, Higashiyama S. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Prostate 2006, 66:1092-1099. 10.1002/pros.20443, 16637071.
22. Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, Hashimoto K, Higashiyama S. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 2007, 26:339-348. 10.1038/sj.onc.1209800, 16862184.
23. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998, 26:362-367. 10.1093/nar/26.1.362, 147251, 9399875.
24. Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci USA 1997, 94:14553-14558. 10.1073/pnas.94.26.14553, 25052, 9405651.
25. Qin P, Haberbusch JM, Zhang Z, Soprano KJ, Soprano DR. Pre-B cell leukemia transcription factor (PBX) proteins are important mediators for retinoic acid-dependent endodermal and neuronal differentiation of mouse embryonal carcinoma P19 cells. J Biol Chem 2004, 279:16263-16271. 10.1074/jbc.M313938200, 14742427.
26. Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res 2006, 66:8598-8607. 10.1158/0008-5472.CAN-06-1228, 16951173.
27. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 2008, 29:169-181. 10.1016/j.yfrne.2007.10.005, 2386261, 18093638.
28. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010, 17:F19-F36. 10.1677/ERC-09-0184, 19779035.
29. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67:6130-6135. 10.1158/0008-5472.CAN-07-0533, 17616669.
30. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008, 27:1788-1793. 10.1038/sj.onc.1210809, 17891175.
31. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008, 68:6162-6170. 10.1158/0008-5472.CAN-08-0144, 2597340, 18676839.
32. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009, 16:206-216.
33. Coppola V, De MR, Bonci D. MicroRNAs and prostate cancer. Endocr Relat Cancer 2010, 17:F1-17. 10.1677/ERC-09-0172, 19779034.
34. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, et al. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009, 69:7165-7169. 10.1158/0008-5472.CAN-09-1448, 2861586, 19738047.
35. Dong Q, Meng P, Wang T, Qin W, Qin W, Wang F, Yuan J, Chen Z, Yang A, Wang H. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One 2010, 5:e10147. 10.1371/journal.pone.0010147, 2854685, 20418948.
36. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
37. Crijns AP, de GP, Geerts D, Ten Hoor KA, Hollema H, van der ST, Hofstra RM, de Bock GH, de JS, van der Zee AG, et al. MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer 2007, 43:2495-2505. 10.1016/j.ejca.2007.08.025, 17949970.